| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Sep 3 | D | 83,690 | — | — |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Sep 3 | D | 124,962 | — | — |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Sep 3 | D | 110,665 | — | — |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Sep 3 | D | 167,123 | — | — |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Sep 2 | D | 1,375 | $135.06 | $186K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Aug 5 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Aug 5 | SPLAN | 5,500 | $134.17 | $738K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Aug 5 | MPLAN | 4,125 | $22.86 | $94K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jul 14 | G | 8,000 | $0.00 | — |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Jul 1 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jul 1 | SPLAN | 5,500 | $132.74 | $730K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jul 1 | MPLAN | 4,125 | $22.86 | $94K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jun 22 | SPLAN | 26,400 | $132.60 | $3.5M |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | Jun 12 | SPLAN | 12,583 | $70.11 | $882K |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | Jun 11 | SPLAN | 22,417 | $70.13 | $1.6M |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Jun 3 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jun 3 | SPLAN | 5,500 | $78.71 | $433K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jun 3 | MPLAN | 4,125 | $22.86 | $94K |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDirDERIV | Jun 2 | A | 9,136 | $0.00 | —? |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDirDERIV | May 21 | MPLAN | 11,667 | $0.00 | —? |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDirDERIV | May 21 | MPLAN | 11,904 | $0.00 | —? |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDirDERIV | May 21 | MPLAN | 38,689 | $0.00 | —? |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | May 21 | SPLAN | 13,235 | $59.97 | $794K |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | May 21 | SPLAN | 53,447 | $59.10 | $3.2M |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | May 21 | SPLAN | 38,318 | $58.43 | $2.2M |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | May 21 | MPLAN | 11,667 | $11.77 | $137K |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | May 21 | MPLAN | 11,904 | $7.80 | $93K |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | May 21 | MPLAN | 38,689 | $6.84 | $265K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | May 6 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | May 6 | SPLAN | 1,800 | $84.60 | $152K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | May 6 | SPLAN | 3,700 | $83.92 | $311K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | May 6 | MPLAN | 4,125 | $22.86 | $94K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Apr 1 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Apr 1 | SPLAN | 100 | $85.89 | $9K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Apr 1 | SPLAN | 2,702 | $85.33 | $231K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Apr 1 | SPLAN | 2,698 | $84.31 | $227K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Apr 1 | MPLAN | 4,125 | $22.86 | $94K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Mar 4 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Mar 4 | SPLAN | 200 | $73.26 | $15K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Mar 4 | SPLAN | 2,075 | $71.98 | $149K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Mar 4 | SPLAN | 3,225 | $70.33 | $227K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Mar 4 | MPLAN | 4,125 | $22.86 | $94K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Feb 4 | MPLAN | 4,125 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Feb 4 | SPLAN | 200 | $68.94 | $14K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Feb 4 | SPLAN | 100 | $67.88 | $7K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Feb 4 | SPLAN | 1,299 | $66.85 | $87K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Feb 4 | SPLAN | 1,420 | $65.83 | $93K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Feb 4 | SPLAN | 2,481 | $64.88 | $161K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Feb 4 | MPLAN | 4,125 | $22.86 | $94K |
| Oruka Therapeutics, Inc. | ORKA | Carl DambkowskiDir | Jan 23 | J | 116,483 | $0.00 | — |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Jan 7 | MPLAN | 14,025 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jan 7 | SPLAN | 100 | $80.06 | $8K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jan 7 | SPLAN | 826 | $79.04 | $65K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jan 7 | SPLAN | 14,820 | $77.90 | $1.2M |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jan 7 | SPLAN | 2,954 | $77.13 | $228K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Jan 7 | MPLAN | 14,025 | $22.86 | $321K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Jan 2 | A | 83,690 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Dec 4 | SPLAN | 10,900 | $75.00 | $818K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMODERIV | Nov 5 | MPLAN | 8,060 | $0.00 | —? |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Nov 5 | SPLAN | 678 | $56.51 | $38K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Nov 5 | SPLAN | 5,607 | $55.58 | $312K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Nov 5 | SPLAN | 2,200 | $54.83 | $121K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Nov 5 | SPLAN | 2,300 | $53.62 | $123K |
| Apogee Therapeutics, Inc. | APGE | Carl DambkowskiCMO | Nov 5 | MPLAN | 8,060 | $22.86 | $184K |